Tapering Cyclobenzaprine

Introduction to Tapering

• Cyclobenzaprine should be tapered gradually over 2 to 3 weeks to prevent withdrawal symptoms, as recommended by the Mayo Clinic Proceedings 1, 2, 3

Understanding Cyclobenzaprine and Withdrawal

• Cyclobenzaprine is an oral centrally acting 5-HT2 receptor antagonist that functions as a skeletal muscle relaxant, with both peripheral and central anticholinergic activity and can cause norepinephrine potentiation 1, 2
• With long-term use, patients can experience withdrawal symptoms including malaise, nausea, and headache for 2-4 days after discontinuation, which are uncomfortable but not life-threatening 3

Recommended Tapering Schedule

• For a patient on cyclobenzaprine 10 mg three times daily, a recommended tapering schedule is to reduce to 10 mg twice daily and 5 mg once daily (25 mg total) in week 1, then to 5 mg three times daily (15 mg total) in week 2, and finally to 5 mg twice daily (10 mg total) in week 3, before discontinuing completely 1, 3

Monitoring During Tapering

• Monitoring during tapering should include watching for withdrawal symptoms such as malaise, nausea, and headache, as well as rebound muscle spasm or pain 1, 3
• If withdrawal symptoms become problematic, the taper should be slowed by extending each step to 10-14 days 4

Special Considerations

• Elderly patients or those with hepatic or renal dysfunction may require a more gradual taper due to increased sensitivity to medication changes 1, 3
• Potential drug interactions, especially with other CNS depressants, should be considered as they may complicate the tapering process 5
• Concurrent use with monoamine oxidase inhibitors should be avoided due to the risk of serotonin syndrome 3

Alternative Approaches

• For patients experiencing significant withdrawal symptoms, adjunctive medications such as trazodone or gabapentin for anxiety or insomnia, and standard anti-nausea medications for gastrointestinal discomfort, may be considered 4